Kaplan-Meier analyses reveal improved survival outcomes in NRAS wild-type melanoma, indicating cGAS-STING may enhance antitumor immunity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: